Global Assisted Reproductive Technology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 08-Nov-2022
No. of pages: 105
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Assisted Reproductive Technology companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Assisted Reproductive Technology market. Further, it explains the major drivers and regional dynamics of the global Assisted Reproductive Technology market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Vitrolife

- Ferring Pharmaceuticals

- Irvine Scientific

- Cook Medical

- CellCura

- EMD Serono

- Esco Micro

- IKS International (Gonagen Medikal)

- INVO Bioscience

- IVFtech

- Smiths Medical

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Assisted Reproductive Technology Segment by Type

- General

- Fertility Medication

- In Vitro Fertilization

- Others

Assisted Reproductive Technology Segment by Application

- Fertility Clinics

- Hospitals

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Assisted Reproductive Technology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Assisted Reproductive Technology market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Assisted Reproductive Technology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Assisted Reproductive Technology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Assisted Reproductive Technology revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Assisted Reproductive Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Assisted Reproductive Technology revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Vitrolife, Ferring Pharmaceuticals, Irvine Scientific, Cook Medical, CellCura, EMD Serono, Esco Micro, IKS International (Gonagen Medikal) and INVO Bioscience, etc.

Global Assisted Reproductive Technology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Assisted Reproductive Technology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 General
1.2.3 Fertility Medication
1.2.4 In Vitro Fertilization
1.2.5 Others
1.3 Market by Application
1.3.1 Global Assisted Reproductive Technology Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Assisted Reproductive Technology Market Size (2017-2028)
2.2 Assisted Reproductive Technology Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Assisted Reproductive Technology Market Size by Region (2017-2022)
2.4 Global Assisted Reproductive Technology Market Size Forecast by Region (2023-2028)
2.5 Global Top Assisted Reproductive Technology Countries Ranking by Market Size
3 Assisted Reproductive Technology Competitive by Company
3.1 Global Assisted Reproductive Technology Revenue by Players
3.1.1 Global Assisted Reproductive Technology Revenue by Players (2017-2022)
3.1.2 Global Assisted Reproductive Technology Market Share by Players (2017-2022)
3.2 Global Assisted Reproductive Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Assisted Reproductive Technology Revenue
3.4 Global Assisted Reproductive Technology Market Concentration Ratio
3.4.1 Global Assisted Reproductive Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Assisted Reproductive Technology Revenue in 2021
3.5 Global Assisted Reproductive Technology Key Players Head office and Area Served
3.6 Key Players Assisted Reproductive Technology Product Solution and Service
3.7 Date of Enter into Assisted Reproductive Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Assisted Reproductive Technology Breakdown Data by Type
4.1 Global Assisted Reproductive Technology Historic Revenue by Type (2017-2022)
4.2 Global Assisted Reproductive Technology Forecasted Revenue by Type (2023-2028)
5 Global Assisted Reproductive Technology Breakdown Data by Application
5.1 Global Assisted Reproductive Technology Historic Market Size by Application (2017-2022)
5.2 Global Assisted Reproductive Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Assisted Reproductive Technology Revenue by Company (2020-2022)
6.2 North America Assisted Reproductive Technology Revenue by Type (2017-2028)
6.3 North America Assisted Reproductive Technology Revenue by Application (2017-2028)
6.4 North America Assisted Reproductive Technology Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Assisted Reproductive Technology Revenue by Company (2020-2022)
7.2 Europe Assisted Reproductive Technology Revenue by Type (2017-2028)
7.3 Europe Assisted Reproductive Technology Revenue by Application (2017-2028)
7.4 Europe Assisted Reproductive Technology Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Assisted Reproductive Technology Revenue by Company (2020-2022)
8.2 Asia Pacific Assisted Reproductive Technology Revenue by Type (2017-2028)
8.3 Asia Pacific Assisted Reproductive Technology Revenue by Application (2017-2028)
8.4 Asia Pacific Assisted Reproductive Technology Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Assisted Reproductive Technology Revenue by Company (2020-2022)
9.2 Latin America Assisted Reproductive Technology Revenue by Type (2017-2028)
9.3 Latin America Assisted Reproductive Technology Revenue by Application (2017-2028)
9.4 Latin America Assisted Reproductive Technology Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Assisted Reproductive Technology Revenue by Company (2020-2022)
10.2 Middle East and Africa Assisted Reproductive Technology Revenue by Type (2017-2028)
10.3 Middle East and Africa Assisted Reproductive Technology Revenue by Application (2017-2028)
10.4 Middle East and Africa Assisted Reproductive Technology Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Vitrolife
11.1.1 Vitrolife Company Details
11.1.2 Vitrolife Business Overview
11.1.3 Vitrolife Assisted Reproductive Technology Products and Services
11.1.4 Vitrolife Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.1.5 Vitrolife Assisted Reproductive Technology SWOT Analysis
11.1.6 Vitrolife Recent Developments
11.2 Ferring Pharmaceuticals
11.2.1 Ferring Pharmaceuticals Company Details
11.2.2 Ferring Pharmaceuticals Business Overview
11.2.3 Ferring Pharmaceuticals Assisted Reproductive Technology Products and Services
11.2.4 Ferring Pharmaceuticals Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.2.5 Ferring Pharmaceuticals Assisted Reproductive Technology SWOT Analysis
11.2.6 Ferring Pharmaceuticals Recent Developments
11.3 Irvine Scientific
11.3.1 Irvine Scientific Company Details
11.3.2 Irvine Scientific Business Overview
11.3.3 Irvine Scientific Assisted Reproductive Technology Products and Services
11.3.4 Irvine Scientific Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.3.5 Irvine Scientific Assisted Reproductive Technology SWOT Analysis
11.3.6 Irvine Scientific Recent Developments
11.4 Cook Medical
11.4.1 Cook Medical Company Details
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Assisted Reproductive Technology Products and Services
11.4.4 Cook Medical Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.4.5 Cook Medical Assisted Reproductive Technology SWOT Analysis
11.4.6 Cook Medical Recent Developments
11.5 CellCura
11.5.1 CellCura Company Details
11.5.2 CellCura Business Overview
11.5.3 CellCura Assisted Reproductive Technology Products and Services
11.5.4 CellCura Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.5.5 CellCura Assisted Reproductive Technology SWOT Analysis
11.5.6 CellCura Recent Developments
11.6 EMD Serono
11.6.1 EMD Serono Company Details
11.6.2 EMD Serono Business Overview
11.6.3 EMD Serono Assisted Reproductive Technology Products and Services
11.6.4 EMD Serono Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.6.5 EMD Serono Assisted Reproductive Technology SWOT Analysis
11.6.6 EMD Serono Recent Developments
11.7 Esco Micro
11.7.1 Esco Micro Company Details
11.7.2 Esco Micro Business Overview
11.7.3 Esco Micro Assisted Reproductive Technology Products and Services
11.7.4 Esco Micro Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.7.5 Esco Micro Assisted Reproductive Technology SWOT Analysis
11.7.6 Esco Micro Recent Developments
11.8 IKS International (Gonagen Medikal)
11.8.1 IKS International (Gonagen Medikal) Company Details
11.8.2 IKS International (Gonagen Medikal) Business Overview
11.8.3 IKS International (Gonagen Medikal) Assisted Reproductive Technology Products and Services
11.8.4 IKS International (Gonagen Medikal) Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.8.5 IKS International (Gonagen Medikal) Assisted Reproductive Technology SWOT Analysis
11.8.6 IKS International (Gonagen Medikal) Recent Developments
11.9 INVO Bioscience
11.9.1 INVO Bioscience Company Details
11.9.2 INVO Bioscience Business Overview
11.9.3 INVO Bioscience Assisted Reproductive Technology Products and Services
11.9.4 INVO Bioscience Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.9.5 INVO Bioscience Assisted Reproductive Technology SWOT Analysis
11.9.6 INVO Bioscience Recent Developments
11.10 IVFtech
11.10.1 IVFtech Company Details
11.10.2 IVFtech Business Overview
11.10.3 IVFtech Assisted Reproductive Technology Products and Services
11.10.4 IVFtech Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.10.5 IVFtech Assisted Reproductive Technology SWOT Analysis
11.10.6 IVFtech Recent Developments
11.11 Smiths Medical
11.11.1 Smiths Medical Company Details
11.11.2 Smiths Medical Business Overview
11.11.3 Smiths Medical Assisted Reproductive Technology Products and Services
11.11.4 Smiths Medical Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022)
11.11.5 Smiths Medical Recent Developments
12 Assisted Reproductive Technology Market Dynamics
12.1 Assisted Reproductive Technology Market Trends
12.2 Assisted Reproductive Technology Market Drivers
12.3 Assisted Reproductive Technology Market Challenges
12.4 Assisted Reproductive Technology Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Assisted Reproductive Technology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of General
Table 3. Key Players of Fertility Medication
Table 4. Key Players of In Vitro Fertilization
Table 5. Key Players of Others
Table 6. Global Assisted Reproductive Technology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Assisted Reproductive Technology Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Assisted Reproductive Technology Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Assisted Reproductive Technology Revenue Market Share by Region (2017-2022)
Table 10. Global Assisted Reproductive Technology Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Assisted Reproductive Technology Market Share by Players (2017-2022)
Table 12. Global Top Assisted Reproductive Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technology as of 2021)
Table 13. Ranking of Global Top Assisted Reproductive Technology Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Assisted Reproductive Technology Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Assisted Reproductive Technology Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Assisted Reproductive Technology Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Assisted Reproductive Technology Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Assisted Reproductive Technology Revenue Market Share by Type (2017-2022)
Table 21. Global Assisted Reproductive Technology Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Assisted Reproductive Technology Revenue Market Share by Type (2023-2028)
Table 23. Global Assisted Reproductive Technology Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Assisted Reproductive Technology Revenue Market Share by Application (2017-2022)
Table 25. Global Assisted Reproductive Technology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Assisted Reproductive Technology Revenue Market Share by Application (2023-2028)
Table 27. North America Assisted Reproductive Technology Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Assisted Reproductive Technology Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Assisted Reproductive Technology Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Assisted Reproductive Technology Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Assisted Reproductive Technology Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Assisted Reproductive Technology Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Assisted Reproductive Technology Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Assisted Reproductive Technology Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Assisted Reproductive Technology Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Assisted Reproductive Technology Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Assisted Reproductive Technology Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Assisted Reproductive Technology Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Assisted Reproductive Technology Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Assisted Reproductive Technology Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Assisted Reproductive Technology Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Assisted Reproductive Technology Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Assisted Reproductive Technology Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Assisted Reproductive Technology Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Assisted Reproductive Technology Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Assisted Reproductive Technology Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Assisted Reproductive Technology Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Assisted Reproductive Technology Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Assisted Reproductive Technology Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Assisted Reproductive Technology Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Assisted Reproductive Technology Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Assisted Reproductive Technology Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Assisted Reproductive Technology Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Assisted Reproductive Technology Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Assisted Reproductive Technology Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Assisted Reproductive Technology Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Assisted Reproductive Technology Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Assisted Reproductive Technology Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Assisted Reproductive Technology Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Assisted Reproductive Technology Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Assisted Reproductive Technology Revenue by Country (2023-2028) & (US$ Million)
Table 62. Vitrolife Company Details
Table 63. Vitrolife Business Overview
Table 64. Vitrolife Assisted Reproductive Technology Product and Services
Table 65. Vitrolife Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 66. Vitrolife Assisted Reproductive Technology SWOT Analysis
Table 67. Vitrolife Recent Developments
Table 68. Ferring Pharmaceuticals Company Details
Table 69. Ferring Pharmaceuticals Business Overview
Table 70. Ferring Pharmaceuticals Assisted Reproductive Technology Product and Services
Table 71. Ferring Pharmaceuticals Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 72. Ferring Pharmaceuticals Assisted Reproductive Technology SWOT Analysis
Table 73. Ferring Pharmaceuticals Recent Developments
Table 74. Irvine Scientific Company Details
Table 75. Irvine Scientific Business Overview
Table 76. Irvine Scientific Assisted Reproductive Technology Product and Services
Table 77. Irvine Scientific Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 78. Irvine Scientific Assisted Reproductive Technology SWOT Analysis
Table 79. Irvine Scientific Recent Developments
Table 80. Cook Medical Company Details
Table 81. Cook Medical Business Overview
Table 82. Cook Medical Assisted Reproductive Technology Product and Services
Table 83. Cook Medical Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 84. Cook Medical Assisted Reproductive Technology SWOT Analysis
Table 85. Cook Medical Recent Developments
Table 86. CellCura Company Details
Table 87. CellCura Business Overview
Table 88. CellCura Assisted Reproductive Technology Product and Services
Table 89. CellCura Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 90. CellCura Assisted Reproductive Technology SWOT Analysis
Table 91. CellCura Recent Developments
Table 92. EMD Serono Company Details
Table 93. EMD Serono Business Overview
Table 94. EMD Serono Assisted Reproductive Technology Product and Services
Table 95. EMD Serono Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 96. EMD Serono Assisted Reproductive Technology SWOT Analysis
Table 97. EMD Serono Recent Developments
Table 98. Esco Micro Company Details
Table 99. Esco Micro Business Overview
Table 100. Esco Micro Assisted Reproductive Technology Product and Services
Table 101. Esco Micro Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 102. Esco Micro Assisted Reproductive Technology SWOT Analysis
Table 103. Esco Micro Recent Developments
Table 104. IKS International (Gonagen Medikal) Company Details
Table 105. IKS International (Gonagen Medikal) Business Overview
Table 106. IKS International (Gonagen Medikal) Assisted Reproductive Technology Product and Services
Table 107. IKS International (Gonagen Medikal) Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 108. IKS International (Gonagen Medikal) Assisted Reproductive Technology SWOT Analysis
Table 109. IKS International (Gonagen Medikal) Recent Developments
Table 110. INVO Bioscience Company Details
Table 111. INVO Bioscience Business Overview
Table 112. INVO Bioscience Assisted Reproductive Technology Product and Services
Table 113. INVO Bioscience Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 114. INVO Bioscience Assisted Reproductive Technology SWOT Analysis
Table 115. INVO Bioscience Recent Developments
Table 116. IVFtech Company Details
Table 117. IVFtech Business Overview
Table 118. IVFtech Assisted Reproductive Technology Product and Services
Table 119. IVFtech Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 120. IVFtech Assisted Reproductive Technology SWOT Analysis
Table 121. IVFtech Recent Developments
Table 122. Smiths Medical Company Details
Table 123. Smiths Medical Business Overview
Table 124. Smiths Medical Assisted Reproductive Technology Product and Services
Table 125. Smiths Medical Assisted Reproductive Technology Revenue in Assisted Reproductive Technology Business (2017-2022) & (US$ Million)
Table 126. Smiths Medical Recent Developments
Table 127. Assisted Reproductive Technology Market Trends
Table 128. Assisted Reproductive Technology Market Drivers
Table 129. Assisted Reproductive Technology Market Challenges
Table 130. Assisted Reproductive Technology Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Assisted Reproductive Technology Sales Market Share by Type: 2021 VS 2028
Figure 2. General Features
Figure 3. Fertility Medication Features
Figure 4. In Vitro Fertilization Features
Figure 5. Others Features
Figure 6. Global Assisted Reproductive Technology Sales Market Share by Application: 2021 VS 2028
Figure 7. Fertility Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Assisted Reproductive Technology Report Years Considered
Figure 11. Global Assisted Reproductive Technology Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Assisted Reproductive Technology Market Size 2017-2028 (US$ Million)
Figure 13. Global Assisted Reproductive Technology Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Assisted Reproductive Technology Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Assisted Reproductive Technology Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Assisted Reproductive Technology Market Share by Players in 2021
Figure 17. Global Top Assisted Reproductive Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technology as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Assisted Reproductive Technology Revenue in 2021
Figure 19. North America Assisted Reproductive Technology Revenue Market Share by Company in 2021
Figure 20. North America Assisted Reproductive Technology Revenue Market Share by Type (2017-2028)
Figure 21. North America Assisted Reproductive Technology Revenue Market Share by Application (2017-2028)
Figure 22. North America Assisted Reproductive Technology Revenue Share by Country (2017-2028)
Figure 23. U.S. Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Assisted Reproductive Technology Revenue Market Share by Company in 2021
Figure 26. Europe Assisted Reproductive Technology Revenue Market Share by Type (2017-2028)
Figure 27. Europe Assisted Reproductive Technology Revenue Market Share by Application (2017-2028)
Figure 28. Europe Assisted Reproductive Technology Revenue Share by Country (2017-2028)
Figure 29. Germany Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 30. France Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Assisted Reproductive Technology Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Assisted Reproductive Technology Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Assisted Reproductive Technology Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Assisted Reproductive Technology Revenue Share by Region (2017-2028)
Figure 38. China Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 41. India Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Assisted Reproductive Technology Revenue Market Share by Company in 2021
Figure 50. Latin America Assisted Reproductive Technology Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Assisted Reproductive Technology Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Assisted Reproductive Technology Revenue Share by Country (2017-2028)
Figure 53. Mexico Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Assisted Reproductive Technology Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Assisted Reproductive Technology Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Assisted Reproductive Technology Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Assisted Reproductive Technology Revenue Share by Country (2017-2028)
Figure 60. Turkey Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 62. U.A.E Assisted Reproductive Technology Revenue (2017-2028) & (US$ Million)
Figure 63. Vitrolife Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 64. Ferring Pharmaceuticals Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 65. Irvine Scientific Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 66. Cook Medical Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 67. CellCura Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 68. EMD Serono Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 69. Esco Micro Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 70. IKS International (Gonagen Medikal) Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 71. INVO Bioscience Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 72. IVFtech Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 73. Smiths Medical Revenue Growth Rate in Assisted Reproductive Technology Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs